Search Results - "STEVEN SHAK" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

by Klein, Eric A, Cooperberg, Matthew R, Magi-Galluzzi, Cristina, Simko, Jeffry P, Falzarano, Sara M, Maddala, Tara, Chan, June M, Li, Jianbo, Cowan, Janet E, Tsiatis, Athanasios C, Cherbavaz, Diana B, Pelham, Robert J, Tenggara-Hunter, Imelda, Baehner, Frederick L, Knezevic, Dejan, Febbo, Phillip G, Shak, Steven, Kattan, Michael W, Lee, Mark, Carroll, Peter R
Published in European urology (01.09.2014)

Get full text

Journal Article

Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

by DOWSETT, Mitch, CUZICK, Jack, HOWELL, Anthony, BUGARINI, Roberto, BAEHNER, Frederick L, SHAK, Steven, WALE, Christopher, FORBES, John, MALLON, Elizabeth A, SALTER, Janine, QUINN, Emma, DUNBIER, Anita, BAUM, Michael, BUZDAR, Aman
Published in Journal of clinical oncology (10.04.2010)

Get full text

Journal Article

Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer

Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer

by GRAY, Richard G, QUIRKE, Philip, WATSON, Drew, SHAK, Steven, KERR, David J, HANDLEY, Kelly, LOPATIN, Margarita, MAGILL, Laura, BAEHNER, Frederick L, BEAUMONT, Claire, CLARK-LANGONE, Kim M, YOSHIZAWA, Carl N, LEE, Mark
Published in Journal of clinical oncology (10.12.2011)

Get full text

Journal Article

Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

by Mamounas, Eleftherios P, Tang, Gong, Fisher, Bernard, Paik, Soonmyung, Shak, Steven, Costantino, Joseph P, Watson, Drew, Geyer, Jr, Charles E, Wickerham, D Lawrence, Wolmark, Norman
Published in Journal of clinical oncology (01.04.2010)

Get full text

Journal Article

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

by Paik, Soonmyung, Tang, Gong, Shak, Steven, Kim, Chungyeul, Baker, Joffre, Kim, Wanseop, Cronin, Maureen, Baehner, Frederick L, Watson, Drew, Bryant, John, Costantino, Joseph P, Geyer, Jr, Charles E, Wickerham, D Lawrence, Wolmark, Norman
Published in Journal of clinical oncology (10.08.2006)

Get full text

Journal Article

Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor-Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14

Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor-Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14

by Wolmark, Norman, Mamounas, Eleftherios P, Baehner, Frederick L, Butler, Steven M, Tang, Gong, Jamshidian, Farid, Sing, Amy P, Shak, Steven, Paik, Soonmyung
Published in Journal of clinical oncology (10.07.2016)

Get full text

Journal Article

Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin

Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin

by Yothers, Greg, O'Connell, Michael J, Lee, Mark, Lopatin, Margarita, Clark-Langone, Kim M, Millward, Carl, Paik, Soonmyung, Sharif, Saima, Shak, Steven, Wolmark, Norman
Published in Journal of clinical oncology (20.12.2013)

Get full text

Journal Article

Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin

Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin

by Michael J. O'Connell, Ian Lavery, Greg Yothers, Soonmyung Paik, Kim M. Clark-Langone, Margarita Lopatin, Drew Watson, Frederick L. Baehner, Steven Shak, Joffre Baker, J. Wayne Cowens, Norman Wolmark
Published in Journal of clinical oncology (01.09.2010)

Get full text

Journal Article

Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581

Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581

by VENOOK, Alan P, NIEDZWIECKI, Donna, GOLDBERG, Richard M, MAHMOUD, Najjia N, WARREN, Robert S, SCHILSKY, Richard L, BERTAGNOLLI, Monica M, LOPATIN, Margarita, XING YE, LEE, Mark, FRIEDMAN, Paula N, FRANKEL, Wendy, CLARK-LANGONE, Kim, MILLWARD, Carl, SHAK, Steven
Published in Journal of clinical oncology (10.05.2013)

Get full text

Journal Article

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

by Paik, Soonmyung, Shak, Steven, Tang, Gong, Kim, Chungyeul, Baker, Joffre, Cronin, Maureen, Baehner, Frederick L, Walker, Michael G, Watson, Drew, Park, Taesung, Hiller, William, Fisher, Edwin R, Wickerham, D. Lawrence, Bryant, John, Wolmark, Norman
Published in The New England journal of medicine (30.12.2004)

Get full text

Journal Article

Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor–Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors

Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor–Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors

by GONG TANG, CUZICK, Jack, COSTANTINO, Joseph P, DOWSETT, Mitch, FORBES, John F, CRAGER, Michael, MAMOUNAS, Eleftherios P, SHAK, Steven, WOLMARK, Norman
Published in Journal of clinical oncology (20.11.2011)

Get full text

Journal Article

Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

Prognostic Utility of the 21-Gene Assay in Hormone Receptor–Positive Operable Breast Cancer Compared With Classical Clinicopathologic Features

by GOLDSTEIN, Lori J, GRAY, Robert, SLEDGE, George W, PEREZ, Edith A, SHULMAN, Lawrence N, MARTINO, Silvana, SPARANO, Joseph A, BADVE, Sunil, CHILDS, Barrett H, YOSHIZAWA, Carl, ROWLEY, Steve, SHAK, Steven, BAEHNER, Frederick L, RAVDIN, Peter M, DAVIDSON, Nancy E
Published in Journal of clinical oncology (01.09.2008)

Get full text

Journal Article

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

by Vogel, C. L.
Published in Journal of clinical oncology (01.02.2002)

Get full text

Journal Article

Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience

Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience

by Seidman, A.
Published in Journal of clinical oncology (01.03.2002)

Get full text

Journal Article

Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer

Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer

by KIM, Chungyeul, GONG TANG, FUMAGALLI, Debora, TANIYAMA, Yusuke, LEE, Ahwon, REILLY, Megan L, VOGEL, Victor G, MCCASKILL-STEVENS, Worta, FORD, Leslie G, GEYER, Charles E, LAWRENCE WICKERHAM, D, WOLMARK, Norman, POGUE-GEILE, Katherine L, PAIK, Soonmyung, COSTANTINO, Joseph P, BAEHNER, Frederick L, BAKER, Joffre, CRONIN, Maureen T, WATSON, Drew, SHAK, Steven, BOHN, Olga L
Published in Journal of clinical oncology (01.11.2011)

Get full text

Journal Article

Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer

Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer

by Gianni, Luca, Zambetti, Milvia, Clark, Kim, Baker, Joffre, Cronin, Maureen, Wu, Jenny, Mariani, Gabriella, Rodriguez, Jaime, Carcangiu, Marialuisa, Watson, Drew, Valagussa, Pinuccia, Rouzier, Roman, Symmans, W Fraser, Ross, Jeffrey S, Hortobagyi, Gabriel N, Pusztai, Lajos, Shak, Steven
Published in Journal of clinical oncology (10.10.2005)

Get full text

Journal Article

The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer

The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer

by Nitz, Ulrike, Gluz, Oleg, Kreipe, Hans H., Christgen, Matthias, Kuemmel, Sherko, Baehner, Frederick L., Shak, Steven, Aktas, Bahriye, Braun, Michael, Lüdtke-Heckenkamp, Kerstin, Forstbauer, Helmut, Grischke, Eva-Maria, Nuding, Benno, Darsow, Maren, Schumacher, Claudia, Krauss, Katja, Malter, Wolfram, Thill, Marc, Warm, Mathias, Wuerstlein, Rachel, Kates, Ronald E., Harbeck, Nadia
Published in Therapeutic advances in medical oncology (2020)

Get full text

Journal Article

Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory

Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory

by BADVE, Sunil S, BAEHNER, Frederick L, MARTINO, Silvana, DAVIDSON, Nancy E, SLEDGE, George W, GOLDSTEIN, Lori J, SPARANO, Joseph A, GRAY, Robert P, CHILDS, Barrett H, MADDALA, Tara, LIU, Mei-Lan, ROWLEY, Steve C, SHAK, Steven, PEREZ, Edith D, SHULMAN, Lawrence J
Published in Journal of clinical oncology (20.05.2008)

Get full text

Journal Article

21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer

21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer

by Geyer, Jr, Charles E, Tang, Gong, Mamounas, Eleftherios P, Rastogi, Priya, Paik, Soonmyung, Shak, Steven, Baehner, Frederick L, Crager, Michael, Wickerham, D Lawrence, Costantino, Joseph P, Wolmark, Norman
Published in NPJ breast cancer (14.11.2018)

Get full text

Journal Article

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

by Habel, Laurel A, Shak, Steven, Jacobs, Marlena K, Capra, Angela, Alexander, Claire, Pho, Mylan, Baker, Joffre, Walker, Michael, Watson, Drew, Hackett, James, Blick, Noelle T, Greenberg, Deborah, Fehrenbacher, Louis, Langholz, Bryan, Quesenberry, Charles P
Published in Breast cancer research : BCR (01.01.2006)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[20]